|
Diabetes, Vol 44, Issue 8 929-935, Copyright © 1995 by American Diabetes Association
Decreased degradative enzymes in mesangial cells cultured in high glucose media
DJ Leehey, RH Song, N Alavi and AK Singh
Veterans Affairs Hospital, Hines, IL 60141, USA.
Abnormalities in extracellular matrix degradation may play a pathogenetic
role in diabetic nephropathy. Cultured renal mesangial cells are known to
synthesize increased amounts of matrix proteins when incubated in high
glucose media (e.g., 30 mmol/l). However, the effect of glucose loading on
degradative enzymes is unknown. Primary cultures of rat mesangial cells
were grown until confluent in the presence of fetal calf serum (FCS) and
insulin (0.67 U/ml). Cells were then cultured for 7 days in plastic wells
in either 10 or 30 mmol/l glucose media containing neither FCS nor insulin.
Collagenase activity in media were determined by zymography and
quantitative spectrofluorometry. Cathepsin B and D activities in cell
extracts were measured by spectrofluorometry (using the fluorescent
substrate Z-Arg-Arg-7-amido-4-methylcoumarin) and 125I-labeled hemoglobin
digestion, respectively. Gelatin-degrading activity of live mesangial cells
was also determined. mRNA levels for collagenase IV, cathepsin B, and
cathepsin D were determined by Northern analysis. A major band of
collagenase activity with a molecular size of 72 kDa was observed in all
mesangial cell media. Exposure of cells to high glucose media resulted in
significant reductions in collagenase and cathepsin B activities as well as
impairment in gelatin-degrading activity. Collagenase IV and cathepsin B
and D mRNA levels were also decreased by glucose loading. To exclude the
possibility that glucose loading was injurious to cells, 3H-leucine uptake
(as a measure of protein synthesis) and membrane alkaline phosphatase
activity (as a biochemical marker of viability) were not affected by the
high glucose condition.(ABSTRACT TRUNCATED AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Takahashi, A. Ichihara, Y. Kaneshiro, K. Inomata, M. Sakoda, T. Takemitsu, A. Nishiyama, and H. Itoh
Regression of Nephropathy Developed in Diabetes by (Pro)renin Receptor Blockade
J. Am. Soc. Nephrol.,
July 1, 2007;
18(7):
2054 - 2061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ichihara, F. Suzuki, T. Nakagawa, Y. Kaneshiro, T. Takemitsu, M. Sakoda, A.H.M. N. Nabi, A. Nishiyama, T. Sugaya, M. Hayashi, et al.
Prorenin Receptor Blockade Inhibits Development of Glomerulosclerosis in Diabetic Angiotensin II Type 1a Receptor-Deficient Mice
J. Am. Soc. Nephrol.,
July 1, 2006;
17(7):
1950 - 1961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman
Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test
Diabetes,
November 1, 2005;
54(11):
3305 - 3318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hayashida and H. W. Schnaper
High Ambient Glucose Enhances Sensitivity to TGF-{beta}1 via Extracellular Signal--Regulated Kinase and Protein Kinase C{delta} Activities in Human Mesangial Cells
J. Am. Soc. Nephrol.,
August 1, 2004;
15(8):
2032 - 2041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Vidotti, D. E. Casarini, P. C. Cristovam, C. A. Leite, N. Schor, and M. A. Boim
High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells
Am J Physiol Renal Physiol,
June 1, 2004;
286(6):
F1039 - F1045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Huang, A. Vaag, E. Carlsson, M. Hansson, B. Ahren, and L. Groop
Impaired Cathepsin L Gene Expression in Skeletal Muscle Is Associated With Type 2 Diabetes
Diabetes,
September 1, 2003;
52(9):
2411 - 2418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. V. Kitsiou, A. K. Tzinia, W. G. Stetler-Stevenson, A. F. Michael, W.-W. Fan, B. Zhou, and E. C. Tsilibary
Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells
Am J Physiol Renal Physiol,
April 1, 2003;
284(4):
F671 - F679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Nishimura, H. Naruishi, K. Naruishi, T. Yamada, J. Sasaki, C. Peters, Y. Uchiyama, and Y. Murayama
Cathepsin-L, a Key Molecule in the Pathogenesis of Drug-Induced and I-Cell Disease-Mediated Gingival Overgrowth: A Study with Cathepsin-L-Deficient Mice
Am. J. Pathol.,
December 1, 2002;
161(6):
2047 - 2052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. I. Whiteside and J. A. Dlugosz
Mesangial cell protein kinase C isozyme activation in the diabetic milieu
Am J Physiol Renal Physiol,
June 1, 2002;
282(6):
F975 - F980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Robey, J. Ma, A. V. P. Santos, O. A. Noboa, P. E. Coy, and J. M. Bryson
Regulation of Mesangial Cell Hexokinase Activity and Expression by Heparin-binding Epidermal Growth Factor-like Growth Factor. EPIDERMAL GROWTH FACTORS AND PHORBOL ESTERS INCREASE GLUCOSE METABOLISM VIA A COMMON MECHANISM INVOLVING CLASSIC MITOGEN-ACTIVATED PROTEIN KINASE PATHWAY ACTIVATION AND INDUCTION OF HEXOKINASE II EXPRESSION
J. Biol. Chem.,
April 19, 2002;
277(17):
14370 - 14378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Tsiani, P. Lekas, I. G. Fantus, J. Dlugosz, and C. Whiteside
High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor
Am J Physiol Endocrinol Metab,
January 1, 2002;
282(1):
E161 - E169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mene, C. Caenazzo, F. Pugliese, G. A. Cinotti, A. D'Angelo, S. Garbisa, and G. Gambaro
Monocyte/mesangial cell interactions in high-glucose co-cultures
Nephrol. Dial. Transplant.,
May 1, 2001;
16(5):
913 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. YEVDOKIMOVA, N. A. WAHAB, and R. M. MASON
Thrombospondin-1 Is the Key Activator of TGF-{beta}1 in Human Mesangial Cells Exposed to High Glucose
J. Am. Soc. Nephrol.,
April 1, 2001;
12(4):
703 - 712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. LENZ, S. J. ELLIOT, and W. G. STETLER-STEVENSON
Matrix Metalloproteinases in Renal Development and Disease
J. Am. Soc. Nephrol.,
March 1, 2000;
11(3):
574 - 581.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Robey, J. Ma, and A. V. P. Santos
Regulation of mesangial cell hexokinase activity by PKC and the classic MAPK pathway
Am J Physiol Renal Physiol,
November 1, 1999;
277(5):
F742 - F749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-S. HA, J. L. BARNES, J. L. STEWART, C. W. KO, J. H. MINER, D. R. ABRAHAMSON, J. R. SANES, and B. S. KASINATH
Regulation of Renal Laminin in Mice with Type II Diabetes
J. Am. Soc. Nephrol.,
September 1, 1999;
10(9):
1931 - 1939.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. KAPOR-DREZGIC, X. ZHOU, T. BABAZONO, J. A. DLUGOSZ, T. HOHMAN, and C. WHITESIDE
Effect of High Glucose on Mesangial Cell Protein Kinase C-{delta} and - is Polyol Pathway-Dependent
J. Am. Soc. Nephrol.,
June 1, 1999;
10(6):
1193 - 1203.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|